Life Science


Founded in 2005 out of the world-renowned Gallium Nitride effort under Professors Shuji Nakamura, Jim Speck, and Steve DenBaars at the University of California at Santa Barbara, Inlustra is focusing on the production of next-generation nonpolar Gallium Nitride substrates for a broad range of laser and LED applications. Inlustra's founders have pioneered nonpolar Gallium Nitride research and have successfully ported the fundamental technology to the current production environment.


InnoZen®, Inc. discovers, develops, and markets, or out licenses, innovative over-the-counter (OTC) health products that fulfill unmet consumer need. InnoZen’s goal is to develop high-quality OTC products that successfully treat common consumer health problems while minimizing the risk of side effects. InnoZen maintains a drug research and development facility and a manufacturing plant in Woodland Hills, California.
Furthermore, InnoZen is considered by many to be the preeminent formulator and developer of thin film-strips that deliver drug actives and was the first company...

IYIA Technologies


Approximately 2.4 million diabetic foot ulcers are diagnosed each year in the U.S, many progressing to lower limb amputation. It is estimated that the U.S. healthcare costs for treating diabetic foot ulcers and related amputations exceed $10 billion per year.

Treating diabetic foot ulcers that have continually failed standard care therapies is a frustrating problem. IYIA Technologies, Inc. has been developing and testing a treatment therapy system, O2Misly™, which actually heals these, failed wounds....


 Jointly Health’s team of world-renowned clinicians, mathematicians, scientists, engineers and healthcare executives are building a next-generation remote patient analytics and monitoring platform with the goal to detect changes in a patient’s health state days, weeks and eventually months in advance. With these predictions it becomes possible to act on these changes before a significant health problem develops so that less risky, and lower cost, interventions can be implemented. This will help “at-risk” healthcare organizations make significant reductions in...


 Makucell is a new life science company that utilizes an innovative proprietary regenerative medicine technology to address aging skin, hair and nails in an entirely new way. Using a patent-pending new molecule, Asymmtate™, Makucell has developed non-prescription products that work with the skin’s own stem cells to produce healthier and more youthful appearing skin. Makucell is introducing the Renewnt™ (pronounced “Re-new-int”) brand of products based on its proprietary technology.

Makucell was founded in September 2010 by distinguished researcher...